In 2021, a seizure on a routine walk led to Scott’s diagnosis with a rare, aggressive brain tumor — one so uncommon that few oncologists knew the best course of treatment. Rather than accept that gap, Scott and his family worked with innovative physicians across the country who extended his life more than double the typical expectancy for his diagnosis.

That experience is the reason BeWonderNow exists. We provide seed-funding for early-stage brain cancer research through pilot grants that bridge the gap between innovation and large-scale support — empowering physician-scientists and researchers to accelerate discovery, so the next family facing a diagnosis like Scott’s has more options than he did.